XRAY vs ANGO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

XRAY

57.9
AI Score
VS
ANGO Wins

ANGO

60.3
AI Score

Investment Advisor Scores

XRAY

58score
Recommendation
HOLD

ANGO

60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY ANGO Winner
Forward P/E 6.3291 96.1538 XRAY
PEG Ratio 0.633 1.4079 XRAY
Revenue Growth -4.1% 8.0% ANGO
Earnings Growth 15.2% 0.0% XRAY
Tradestie Score 57.9/100 60.3/100 ANGO
Profit Margin -15.0% -11.5% ANGO
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

XRAY 1M: -18.8% · 3M: -25.0% ANGO 1M: -4.7% · 3M: +15.5%

Current Technical Phase

XRAY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 28

RSI (14): 28.4 · Price: $8.74

ANGO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 43.1 · Price: $15.12

Fundamentals Snapshot

Metric XRAY ANGO
Market Cap — —
Forward P/E 5.8 -68.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.5%
Operating Margin 0.1% -0.1%
EPS -2.69 -0.88
Dividend Yield 0.04% —

Frequently Asked Questions

Based on our detailed analysis, ANGO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.